Showing results (221-230 of 233) with videos related to
Sort By:
Pageof 24
European Journal of Cancer (Oxford, England : 1990)|June 30, 2019
EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancerC R Lindsay, F H Blackhall, A Carmel, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 20, 2025
DNA methyltransferase 3A (DNMT3A) mutations and PD-(L)1 blockade efficacy in non-small-cell lung cancerB Ricciuti, S Scalera, X Wang, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 29, 2013
Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT networkM Beau-Faller, N Prim, A-M Ruppert, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 17, 2021
Antibiotic-exposed patients with non-small-cell lung cancer preserve efficacy outcomes following first-line chemo-immunotherapyA Cortellini, B Ricciuti, F Facchinetti, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 17, 2025
Next-Generation Multicenter Studies: Using Artificial Intelligence to Automatically Process Unstructured Health Records of Patients with Lung Cancer across Multiple InstitutionsM Aldea, L Zullo, V Levrat, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 24, 2020
Treatment of brain metastases in small cell lung cancer: Decision-making amongst a multidisciplinary panel of European expertsP M Putora, G F Fischer, M Früh, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 17, 2022
ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancerA Passaro, N Leighl, F Blackhall, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 28, 2023
Clinical utility of circulating tumor DNA sequencing with a large panel: a National Center for Precision Medicine (PRISM) studyA Bayle, L Belcaid, M Aldea, et al.Eclinicalmedicine|February 3, 2026
Efficacy, safety, and tolerability of arbaclofen in Autistic children and adolescents, the AIMS-2-TRIALS-CT1: a randomized, double-blind, placebo-controlled phase II trialM Parellada, A San José Cáceres, R Delorme, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2025
ESMO basic requirements for AI-based biomarkers in oncology (EBAI)M Aldea, M Salto-Tellez, A Marra, et al.Pageof 24